Liver transplantation for severe hepatic graft-versus-host disease: An analysis of aggregate survival data

Liver Transplantation

Volumn 11, Issue 5, 2005, Pages 525-531

  Barshes, Neal R ^a   Myers, G Douglas ^a   Lee, Dean ^a   Karpen, Saul J ^a   Lee, Timothy C ^a   Patel, Akash J ^a   Finegold, Milton ^b   Goss, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSIDE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MYELODYSPLASTIC SYNDROME; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REGISTER; REOPERATION; SIDEROBLASTIC ANEMIA; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; LIVER TRANSPLANTATION; MALE; REGISTRIES; SEVERITY OF ILLNESS INDEX;

EID: 18944362247     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20389     Document Type: Article

References (38)

1. Bhushan V, Collins RH Jr. Chronic graft-vs-host disease. JAMA 2003;290:2599-2603.
2. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9:215-233.
3. Asfar S, Zhong R, Grant D. Small bowel transplantation. Surg Clin North Am 1994;74:1197-1210.
4. Thompson JS. Intestinal transplantation. Experience in the United States. Eur J Pediatr Surg 1999;9:271-273.
5. Abu-Elmagd K, Reyes J, Todo S, Rao A, Lee R, Irish W, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998;186:512-525.
6. Starzl TE, Todo S, Tzakis A, Alessiani M, Casavilla A, Abu-Elmagd K, et al. The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991;172:335-344.
7. Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003;75:118-126.
8. Au WY, Ma SK, Kwong YL, Ng IO, Hawkins BR, Wan TS, et al. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing. Clin Transplant 2000;14:174-177.
9. Pageaux GP, Perrigault PF, Fabre JM, Portales P, Souche B, Dereure O, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995;9:65-69.
10. Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK. Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant 2004;4:373-377.
11. Dunn SP, Krueger LJ, Butani L, Punnett H. Late onset of severe graft-versus-host disease in a pediatric liver transplant recipient. Transplantation 2001;71:1483-1485.
12. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, et al. Graft-versus-host disease following living donor liver transplantation. Liver Transpl 2004;10:460-464.
13. Knox KS, Behnia M, Smith LR, Vance GH, Busk M, Cummings OW, et al. Acute graft-versus-host disease of the lung after liver transplantation. Liver Transpl 2002;8:968-971.
14. Kimball P, Ham J, Eisenberg M, King A, Fisher R, Rhodes C, et al. Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation. Transplantation 1997;63:1685-1688.
15. Luckraz H, Zagolin M, McNeil K, Wallwork J. Graft-versus-host disease in lung transplantation: 4 case reports and literature review. J Heart Lung Transplant 2003;22:691-697.
16. Pfitzmann R, Hummel M, Grauhan O, Waurick P, Ewert R, Loebe M, et al. Acute graft-versus-host disease after human heart-lung transplantation: a case report. J Thorac Cardiovasc Surg 1997;114:285-287.
17. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990;76:1464-1472.
18. Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000;96:2062-2068.
19. Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K, et al. Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease. Transplantation 2001;72:1924-1929.
20. Mohty M, de Lavallade H, Faucher C, Bilger K, Vey N, Stoppa AM, et al. Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplant 2004;34:527-530.
21. Flowers ME, Martin PJ. Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease. Leuk Lymphoma 2003;44:1141-1146.
22. Chiang KY, Abhyankar S, Bridges K, Godder K, Henslee-Downey JP. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002;73:665-667.
23. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991;77: 1821-1828.
24. Williams DB, Vickers CR. Hepatic complications. In: Atkinson K, ed. Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge, UK: Cambridge University Press, 2000:912-924.
25. Rhodes DF, Lee WM, Wingard JR, Pavy MD, Santos GW, Shaw BW, et al. Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation. Gastroenterology 1990;99:536-538.
26. Marks DI, Dousset B, Robson A, Imvrios G, Buckels JA, Elias E, et al. Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia. Bone Marrow Transplant 1992;10:463-466.
27. Dowlati A, Honore P, Damas P, Deprez M, Delwaide J, Fillet G, et al. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation 1995;60: 106-109.
28. Figuera A, Tomas JF, Otero MJ, Moreno E, Garcia I, Fernandez-Ranada JM. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation. Am J Hematol 1996;52:68-69.
29. Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, et al. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transpl Surg 1996;2:225-232.
30. Urban CH, Deutschmann A, Kerbl R, Lackner H, Schwinger W, Konigsrainer A, et al. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2002;30:535-537.
31. Crawford JM. Graft-Versus-Host Disease of the Liver. In: Ferrara JL, Deeg HJ, Burakoff SJ, eds. Graft-vs.-Host Disease. New York, NY: Marcel Dekker, 1997:315-336.
32. Yau JC, Zander AR, Srigley JR, Verm RA, Stroehlein JR, Korinek JK, et al. Chronic graft-versus-host disease complicated by micronodular cirrhosis and esophageal varices. Transplantation 1986;41:129-130.
33. Knapp AB, Crawford JM, Rappeport JM, Gollan JL. Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1987;92:513-519.
34. Stechschulte DJ Jr, Fishback JL, Emami A, Bhatia P. Secondary biliary cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1990;98:223-225.
35. Geubel AP, Cnudde A, Ferrant A, Latinne D, Rahier J. Diffuse biliary tract involvement mimicking primary sclerosing cholangitis after bone marrow transplantation. J Hepatol 1990;10:23-28.
36. Bismuth H. The need for a consensus agreement on indications of liver transplantation. Hepatology 1994;20:1S-2S.
37. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979;300:1068-1073.
38. Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989;74: 1428-1435.